Skip to content Skip to navigation

News and Press Releases

Apr 21 2016 | Stanford Medicine
The Macromolecular Structure Knowledge Center can help researchers who lack equipment for testing hundreds of different crystallization conditions or expertise in working with challenging molecules.
Mar 31 2016 | Stanford News
When new cancer cells break free of their original tumor, they travel the blood system and land in distant organs to kindle new tumors. ChEM-H faculty fellow Jennifer Cochran and Amato Giaccia designed a decoy drug to prevent cancer's spread.
Mar 31 2016 | Stanford News
ChEM-H faculty fellow Soichi Wakatsuki bridges the Stanford campus and SLAC National Accelerator Laboratory to probe life in atomic detail.
Mar 28 2016 | Stanford Report
Stanford scientists have resurrected a discarded drug that helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
Mar 24 2016 | Stanford News
When molecules won’t crystallize and technology confounds, who you gonna call? Marc Deller and the Stanford ChEM-H Macromolecular Structure Knoweldge Center are helping researchers from a broad range of backgrounds take advantage of the resources at the SLAC National Accelerator Laboratory to...
Mar 22 2016 | Stanford Report
Chemical engineers at Stanford have discovered mechanical properties of the tear film on the eye's surface that can be used to manufacture contact lenses that more closely mimic the eye. By Rosemary Mena-Werth When contact lenses work really well, you forget they are on your eyes. You might not...
Mar 11 2016 | Stanford Medicine
Ami Bhatt is mobilizing Stanford experts to fight the growing threat of cancer in the developing world. By Ruthann Richter As a child growing up in the United States, Ami Bhatt would frequently take trips with her parents back to their native country of India, where she saw a world altogether...
Mar 10 2016 | Stanford Report
Catching a disease in its earliest stages can lead to more effective therapies. Stanford chemists have increased the likelihood of detecting these diseases via a test that is thousands of times more sensitive than current diagnostics. By Bjorn Carey
Feb 19 2016 | Stanford Medicine
A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year. By Jennie Dusheck Researchers at the Stanford University School of Medicine have identified a gene expression “signature” that...
Feb 10 2016 | Stanford Medicine
Teasing apart subtle differences between a protein-shredding structure found in malaria parasites and in human cells enabled researchers to design a compound targeting the parasite without harming human tissue. By Bruce Goldman   Stanford University School of Medicine investigators have...
Jan 13 2016 | Stanford ChEM-H
Stanford and Ecole Polytechnique Fédérale de Lausanne (EPFL) launch an international research exchange program with the support of Firmenich.
Dec 16 2015 | Stanford Medicine
Researchers have developed a new way to use atomic force microscopy to rapidly measure the mechanical properties of cells at the nanometer scale, an advance that could pave the way for better understanding immune disorders and cancer. BY ANDREW MEYERS
A new tool enables researchers to test millions of mutated proteins in a matter of hours or days, speeding the search for new medicines, industrial enzymes and biosensors. By Ramin Skibba All living things require proteins, members of a vast family of molecules that nature "makes to order"...
Sep 23 2015 | Stanford Medicine
A drug that blocks the intestinal pathogen without killing resident, beneficial microbes may prove superior to antibiotics, currently the front-line treatment for the infection. BY Bruce Goldman
Sep 21 2015 | Stanford Report
Researchers stripped a virus of its infectious machinery and turned its benign core into a delivery vehicle that can target sick cells while leaving healthy tissue alone. By Tom Abate Stanford researchers have ripped the guts out of a virus and totally redesigned its core to repurpose its...
Sep 10 2015 | Stanford Report
Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective.
Sep 1 2015
Lingyin Li, whose work focuses on the immune system’s innate ability to fight cancer, joins Stanford as assistant professor in the department of biochemistry and as a fellow of Stanford ChEM-H
Aug 13 2015 | Stanford Report
It typically takes a year to produce hydrocodone from plants, but Christina Smolke, a Stanford ChEM-H fellow, and colleagues have genetically modified yeast to make it in just a few days. The technique could improve access to medicines in impoverished nations, and later be used to develop...
Aug 3 2015 | Stanford Report
Formaldehyde is excellent for preserving cellular structures, but it makes it difficult to pull genetic information from tissue samples. Eric Kool and colleagues including a ChEM-H fellow have developed a catalyst that saves RNA, which could lead to better patient outcomes. By Bjorn Carey A...
Jun 5 2015 | Stanford Report
Carolyn Bertozzi sees chemicals as having personalities and those personalities determine how they behave. She's bringing this vision to her teaching, hoping to help chemistry and biology students as well as the general public understand what's exciting in chemistry. By Amy Adams   To Carolyn...

Pages

Subscribe to